Annual report pursuant to Section 13 and 15(d)

SHARE-BASED COMPENSATION - Additional Information (Details)

v3.22.0.1
SHARE-BASED COMPENSATION - Additional Information (Details) - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based compensation expense $ 6,000,000 $ 2,700,000 $ 4,200,000  
Unrecognized compensation expense $ 200,700,000      
Options granted (in shares) 0   0 0
Options exercised (in shares) 0 0 7,000  
2016 Plan        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of common stock authorized for issuance (in shares) 40,000,000      
Performance-Based Restricted Stock        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based compensation expense $ 0      
Number of awards outstanding (in shares) 30,800,000      
Performance-Based Restricted Stock | Director        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of awards outstanding (in shares) 19,200,000      
Performance-Based Restricted Stock | FID        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of awards outstanding (in shares) 10,800,000      
Award vesting percentage 33.33%      
Performance-Based Restricted Stock | Other Criteria        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of awards outstanding (in shares) 800,000      
Restricted Stock        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of awards outstanding (in shares) 30,804,000 34,961,000    
Antidilutive securities excluded from computation of loss per share amount (in shares) 30,800,000      
Total grant date fair value of restricted stock vested $ 7,400,000 $ 11,700,000 $ 1,200,000  
Stock Options        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Antidilutive securities excluded from computation of loss per share amount (in shares) 11,100,000